Literature DB >> 10974465

Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques.

M D Posner1, J M Quivey, P F Akazawa, P Xia, C Akazawa, L J Verhey.   

Abstract

PURPOSE: To evaluate and compare dose optimization for the treatment of anaplastic thyroid carcinoma using a 3D conformal plan, and two 3D intensity-modulated inverse plans. METHODS AND MATERIALS: After patient immobilization using an alpha cradle and head-mask system, a postoperative CT scan was obtained to delineate the gross tumor volume (GTV), the clinical tumor volume (CTV), and adjacent critical structures. Treatment plans were generated using UM-Plan (University of Michigan), PeacockPlan and Corvus (NOMOS Corporation, Sewickley, PA). Isodoses were displayed in the sagittal, coronal, and multiple axial planes, and dose-volume histograms (DVH) were generated for the GTV, CTV, and critical normal tissues. Treatment times were estimated to compare the practicality of delivering each plan in a busy radiotherapy department.
RESULTS: All three treatment planning systems were able to deliver a minimum dose of 60 Gy to the GTV while keeping the maximum spinal cord dose at or below 45 Gy. However, there were differences in the doses delivered to 50% and 5% of the cord, the minimum CTV dose, and the overall treatment time. The PeacockPlan best spared the uninvolved tissues of the posterior neck, and provided the lowest dose to the cord without compromising the CTV.
CONCLUSIONS: Inverse treatment planning provides superior dose optimization for the treatment of anaplastic thyroid carcinoma. The radiobiologic impact of intensity modulation for this tumor should be further tested clinically.

Entities:  

Mesh:

Year:  2000        PMID: 10974465     DOI: 10.1016/s0360-3016(00)00621-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Authors:  Dan Fan; Jennifer Ma; Andrew C Bell; Andries H Groen; Kyrie S Olsen; Benjamin H Lok; Jonathan E Leeman; Erik Anderson; Nadeem Riaz; Sean McBride; Ian Ganly; Ashok R Shaha; Eric J Sherman; C Jillian Tsai; Jung J Kang; Nancy Y Lee
Journal:  Cancer       Date:  2019-10-08       Impact factor: 6.860

Review 2.  New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Authors:  Nancy Y Lee; Quynh-Thu Le
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

3.  Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma.

Authors:  Wei-Hua Fu; Lu-Hua Wang; Zong-Mei Zhou; Jian-Rong Dai; Yi-Min Hu; Lu-Jun Zhao
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 4.  Anaplastic Thyroid Carcinoma: An Update.

Authors:  Arnaud Jannin; Alexandre Escande; Abir Al Ghuzlan; Pierre Blanchard; Dana Hartl; Benjamin Chevalier; Frédéric Deschamps; Livia Lamartina; Ludovic Lacroix; Corinne Dupuy; Eric Baudin; Christine Do Cao; Julien Hadoux
Journal:  Cancers (Basel)       Date:  2022-02-19       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.